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1. Introduction 
The prevalence of diabetes mellitus (DM) and its probable influence on periodontal disease 
suggests that DM patients will very likely probably become an increasing proportion of the 
patient population seen by both general dentists and periodontists. Many investigators have 
studied the oral manifestations involving periodontitis as a complicating factor in the 
periodontal therapy of DM patients, whose disease may be more prevalent and more severe 
and progress rapidly.1 2 3 Periodontal disease makes chewing difficult or painful, thereby 
leading to an improper diet. On the other hand, uncontrolled periodontal disease may upset 
metabolic control of DM.2 
Until the past 15 years, the management was based on the periodontology model of care, 
and the aim of these methods was to diagnose the problem and resolve it via treatment. 
Consequently, repairs were made, but the periodontitis generally recurred or progressed 
unabated. Disease prevention was not practised. It is clear that the risk of periodontal 
disease varies greatly from one patient to another.4-8 
Today many practitioners are providing better and more complete service to their patients 
because they are beginning to incorporate the principles of the information-intense 
medical model.9 Changes in our political and social structure have affected how health 
care is being managed. With increasing evidence of the influence of periodontal disease 
on systemic health, dentist and hygienists are taking a more intensive look at the risk 
factors associated with its onset and progression. Bacteriology, immunology, genetics, and 
systemic cofactors are often used to determine what is wrong with the patients. Genetic 
knowledge is an important part of the medical model because it allows for a complete and 
comprehensive picture of all of the factors contributing to the patient’s past, current, and 
future status. 
2. Classification and characterization of periodontal diseases 
2.1 Gingivitis 
Gingivitis is an inflammatory pathologic alteration affecting the gingival epithelium and 
connective tissue (Fig.1). Clinical symptoms comprise reddness and swelling of the gingiva, 
bleeding on probing, and a periodontal pocket deph ≥1mm.  
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Fig. 1. Gingivitis  
Gigivitis is characterized by a subgingival microflora that is slightly shifted in favor of 
gramm-negativ, anaerobic bacteria without any periodontopathogenic microorganisms. 
ANUG is the acronym of the acute necrotic ulcerative gingivitis.  
2.2 Chronic Adult Periodontitis (AP) 
The slowly progressing AP is clinically characterized by persistent loss of attachment, a 
positive bleeding on probing (BOP), periodontal pockets depths of 1-3 mm, and slight loss 
of alveolar bone tissue (Fig.2). This is the most common type of periodontitis and generally 
occurs at the age of 30 years or later. It may be either generalized or limited to molars 
and/or incisors. The subgingival microbial panel is slightly shifted in favor of gram-
negative, anaerobic bacteria with an increased amount of periopathogenic microorganizms. 
 
 
Fig. 2. Periodontitis (loss of alveolar bone tissue) 
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2.3 Refractory marginal periodontitis 
Refractory or therapy-resistant AP shows a progressive loss of attachment even with 
diligent mechanical therapy and positive compliance of the patients. This type of 
periodontitis is characterized by a progressive loss of supporting tissue even if treated 
thoroughly. In most cases the lesions compromise more than one tooth  and are infected by 
high concentration s of periodontal pathogens. After a massive degradation of supporting 
tissue the affected teeth are often lost (Fig.3). 
 
 
Fig. 3. Periodontitis (degradation of supporting tissue the affected teeth are often lost) 
2.4 Localised Juvenile Periodontitis (LJP) 
This type usually affects healthy adolescents at the age of 10 to 20 years. It is distinguished 
by a severe, but localized loss of bone tissue combined with the development of deep 
pockets at the first molars and/or the incisors. Actinobacillus actinomycetemcomitans is 
considered to be the marker pathogen for LJP. 
2.5 Rapidly Progressive Periodontitis (RP) 
RPP is mostly seen in patient’s at the age of 20 to 35 years. The patients medical history 
frequently shows a prior LJP. This form of periodontitis is generalized and progresses 
intermittently with severe loss of bone tissue, gingival bleeding and acute inflammation.The 
subgingival oral microflora is characterized by a high concentration of periodontal pathogens. 
3. The oral cavity ecosystem 
The human oral cavity accomodates about 50 billion bacteria belonging to about 400 
different species.10 The various habitats are occupied by microbial populations specifically 
adapted to their enviroments. 
The deep periodontal lesion is a unique eco-system within the oral cavity providing 
particular living conditions. It is the only place within the oral cavity not being flushed by 
saliva. Instead is filled with crevicular fluid. Moreover, the acigen concentration decreases 
progressively with pocket depth creating optimal growth conditions for anaerobic bacteria.1 
www.intechopen.com
  
Type 1 Diabetes Complications 
 
466 
These bacteria lack the enzymes necessary to detoxify oxigen radicals resulting in a severely 
reduced growth or even death in the presence of oxigen. Dispite the great variety of the 
microbial flora only a fraction of the bacterial species is etiologically connected to the 
development of periodontitis. The flora of a healthy sulcus usually consists of aerobic 
grampositive cocci and rods. These bacteria known as „beneficial flora” show no pathogenic 
potential but, by their presence, are able to prevent the colonization is progressing the 
microbial spectrum is shifted in favor of anaerobic gram-negative rods. 
The marker pathogens of periodontitis belong to the group of obligatory anaerobic, black 
pigmented Bacteroides species as Porphyromonas gingivalis and Prevotella intermedia as well as  
Bacteroides forsythus, Treponema denticola, and Actinobacillus actinomycetemcomitans.11,12 A strict 
correlation of the alveolar pocket depth and presence of periodontopathogens could be 
proven by several clinical studies.13,14,15 
Several metabolites produced by the periodontitis-associated pathogens either destroy the 
sorrounding periodontal tissue or inactivate the humoral host defense system. The most 
important virulence factors produced by the three marker pathogens P. gingivalis, P. 
intermedia and A. actinomycetemcomitans.14  
4. Aetiology of periodontitis 
The development of plaque is considered to be the primary cause of periodontitis. Especially 
at the gingival margin plaque hardens to tartar resulting in a mechanical irritation. 
Exotoxins produced by the plaque bacteria diffuse into adjacent tissue and give rise to 
reddening and swelling -the typical clinical characteritics- of gingivitis. After professional 
removal of plaque and dental calculus a healthy periodontium is quickly restored indicating 
that gingivitis is a reversible condition. In case no professional removal of the dental 
calculus is performed the infection will progress and a periodontitis becomes established 
showing the typical clinical characteristics like bleeding on probing (BOP), increasing pocket 
deph and loss of alveolare bone tissue.11 
At the age play a roule development of periodontitis16, and the age of 40 far more teeth are 
lost by periodontitis than by caries.  
Periodontitis associated bacteria are found in low concentration even in the healthy sulcus. 
Therefore, additional factors must exist that determine the onset and the progress of disease. 
In case of an impaired immune system e.g. by stress, medication, hormonal imbalances, 
diabetes or smoking the pathogens utilize the selective advantages for prompt proliferation 
leading to the establishment of an manifest infection of the periodontium.17-20 
5. Genetic component to periodontitis 
For approximately the past 15 years, dental researchers have been focusing on dental 
plaque. Clinicians have made treatment decisions as though the plaque-disease 
interrelationship was quantitative: the more plaque, the more bacteria, the more 
inflammation, the more disease. However, clinical experience demonstrates that not all 
people respond the same way to similar accumulations of plaque. There are patients with a 
lot of plaque who have moderate and advanced disease. Some types of plaque simply are 
more virulent than others. However, clinical experience demonstrates that not all people 
respond the same way to plaque accumulations. Because so much variability respond to 
plaque, and respond to treatment. Some type of plaque symply are more virulent than 
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others. In adults, these bacteria routinely colonize the teeth when tooth cleaning is not 
performed on a regular basis. Although bacteria are essential for the initiation of 
periodontitis, there is currently no mechanism for determing the clinical trajectory of the 
disease for individual patients, i.e., differentiating those patients who  will have a mild to 
moderate form of disease and respond well to simple professional care from those who are 
likely to develop a more severe periodontitis that demands extensive therapy and results in 
tooth mobility. Individual differences in disease progression are dramatic and are often not 
predictable by currently known mechanisms. 
Identification of a risk factors may explain why individual patients do not respond 
uniformly to standard treatment. For example, a patient who is a heavy smoker may not 
heal as soon or as well as expected after treatment. Patients react differently to bacterial 
stimulation. This is a result not only of the type and amount of bacteria but also of the 
underlying genetic characteristics of the patient’s immune system.The cytokines tumor 
necrosis factor alpha(TNFά) and interleukin 1 (IL-1) are key mediators of the inflammatory 
process and modulate the extracellular matrix components and bone which comprise the 
periodontal tissues.The genes encode pro-inflammatory proteins (IL 1A and IL-1B 
producing IL-1 ά and IL-1β). Several genetic polimorphisms have been described in the 
genes of the IL-1 cluster and, in case control studies, associations have been reported with 
increased severity of several chronic inflammatory diseases. 
The genetic risk of developing periodontitis has been investigated by studying families 
and populations as well as twin.21-26 The studies conducted on twins have reported a 
significant genetic component explaining the variation in clinical attachment loss, probing 
depth and gingivitis. An association between the severe chronic form of the disease and a 
composite genotype in the interleukin IL-1ά and IL-1β genes has been reported.21 
However, this association was found only in non-smokers. Other authors have 
subsequently investigated the IL-1ά - IL-1β genotypes with a chronic form of periodontitis 
with different results.27,28 
The genetics influence resistance on periodontal disease has been determined from a wide 
variety of sources.29-32 Genotype positive patients had significantly more clinical expression 
of inflammation, as determined by bleeding on probing. In healthy patients 46.7 % of 
genotype positive patients had bleeding as compared with only 8.6% of genotype-negative 
patients.32,33 Their results from genetic susceptibility testing have the real potential to 
improve patient management. Many of the genetic markers for common disease involve 
polymorphisms in gene sequences involved in cytokine biological activity. Researchers 
know that in healthy subject IL-1 plays a very important role in inflammation and the 
expression of periodontitis. Patients with this genotype progress more rapidly toward 
severe periodontitis and have statistically significant increased inflammation.32 It has been 
established that this genotype occurs in approximately 30% of most of the populations that 
have been tested for this genotype.  
Cells from people with a positive genotype produced up to four times more IL-1 in 
response to the same bacterial challenge.34 Because IL-1 in high concentrations is involved 
with destruction of tissues, this increased IL-1 response may explain the more rapid 
progression of periodontal disease in genotype-positive patients when faced with a 
bacterial challenge in their plaque. For patients with this genetic susceptibility to 
periodontitis, tooth loss was be minimized by good plaque control and definitive 
periodontal therapy.35 
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6. Genetic test for susceptibility to periodontal disease 
Two polymorphisms within the IL-1 gene cluster show a close association with 
periodontitis. One polymorphism is located at position -899 of the Interleukin 1ά gene, the 
other at position +3953 of the Interleukin 1β gene.32,36 Within both polymorphisms allele 1 
harbors a cytidin c, whereas allele 2 carries a thymidin (T) at the respective position. Allele 2 
of the +3953 polymorphism of the IL-1β gene leads to an alteration of the corresponding 
protein resulting in an overproduction of IL-1β.37 This overproduction of IL-1 seems to 
override the feedback mechanisms which normally limit inflammation resulting in the 
development of massive gingival pockets and degradation of periodontal tissue. These data 
allow a risk assessment, defining a patients as PRT-positive or PRT negative, the presence of 
periodontitis risk alleles at positions IL-1ά-889 and IL-1β +3953.  
6.1 GenotypR PRT test 
With the GenotypR PRT test (Hain Lifescience) the base composition and allelic combination 
of the two IL1 loci can be analysed.  The test is a molecular biological assay based on the 
identification of gene loci associated with an elevated risk in developing periodontitis by 
means of highly specific DNA probes. It is based on the analysis of nucleic acids, there is no 
need for viable bacteria to perform the test and no special precautions are required during 
transport.  A detailed sequence analysis has to be performed by additional examinations. 
The GenotypR PRT test is not a diagnostic test for periodontal disease. It is rather a test 
determing the patient’s genetic susceptibility to developing severe, generalized periodontitis 
in the future and helps to plan a comprehensive therapy. Processing and interpretation of 
the test is performed in clinical laboratories from a buccal swab containing cells of the 
mucous membrane of the patient’s cheek. 
7. Indications for microbiological testing of the subgingival flora 
It is generally accepted that periodontitis is initiated by the establishment of a specific 
subgingival bacterial flora. Some of the marker pathogens belong to the group of obligatory 
anaerobic, black pigmented Bacteroides species such as Porphyromonas gingivalis and Prevotella 
intermedia. In addition, the bacterial species Actinobacillus actinomycetemcomitans 
(Haemophilus a.), Bacteroidea forsythus, and Treponema denticola play a pivotal role in the 
initiation of periodontal disease (Table 1).  
 
Strong evidence for etiology Moderate evidence for etiology 
Actinobacillus 
actinomycetemcomitans 
Campylobacter rectus 
Porphyromonas gingivalis Eubacterium nodatum 
Bacteroides forsytus Fusobacterium nucleatum 
 Prevotella intermedia 
 Peptostreptococcus micros 
 Streptococcus intermedius-complex 
 Treponema denticola 
Table 1. Specific Bacteria Associated with Periodontal Disease (Annals of Periodontology 
1:928,1996) 
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7.1 MicroDentR test 
Like GenotypR PRT the microDentR test is a molecular biological diagnostic device. Since it 
is based on the analysis of nucleic acids, there is no need for viable bacteria to perform the 
test and no special precautions are requireed during transport. The microDentR test a highly 
sensitive and highly specific molecular bological PCR-DNA-probe method. Due to the high 
specificity of the PCR, any potential contamination of the probe by concomitant flora has no 
influence on the test results. 
A defined cut-off ensures that every positive test result is of clinical relevance and that 
bacterial concentrations present in a healthy sulcus lead to a negative result. Sampling is 
performed from the gingival pocket with strile paper points. These marker species can be 
detected with the microDentR test: Actinobacillus actinomycetemcomitans, Porphyromonas 
gingivalis, Prevotella intermedia, Bacteroides forsythus, Treponema denticola. 
Periodontopathogenic bacteria activate inflammatory mechanisms within the local 
periodontal tissue throught the production of toxins and other metabolites. The degree of 
this response depens on the general health and immunologic state of the patients. Besides 
that, exogenic risk factors such as haevy smoking, stress and medication can negatively 
influence the progression of periodontal disease. Patients who in addition are PRT-positive 
suffer from an overproduction of IL-1 leading to a significantly increased immunologic 
response to the presence of  periodontopathogenic bacteria. This individuals therefore are at 
an even higher risk for developing severe disease and losing teeth. Knowledge of the IL—1 
genotype, the bacterial load, and possible additional risk factors allow for the prediction of 
the patient’s future periodontal status including the risk of further tooth loss. 
8. Risk factor influence on periodontitis in type 1 DM 
A number of studies have demonstrated a relationship between DM and periodontal 
diseases, which are among the most prevalent complications of DM.38-57 Individuals with 
DM tend to have a higher prevalence of periodontal diseases and more severe and rapidly 
progressing forms than those who do not have DM.41,48 DM is a known risk factor for 
periodontitis in adults. Seppälä et al.49 demonstrated that patients with type 1 DM exhibit a 
higher degree of attachment loss and bone loss than control subjects under similar dental 
plaque conditions. This finding was confirmed in a follow-up site-by-site study by the same 
authors.50  
The changes in the periodontal conditions are mostly expressed in the first year of the 
disease, and the damage to the periodontium which develops at this time is not greatly 
influeced in the further course of the disease (Fig 4). 
It is an interesting result that younger DM subjects display more periodontal destruction 
than do non-DM subjects at a later age. In the all-age groups, the periodontal status varied 
according to the age of the patient at the onset of DM. This suggests that the early onset of 
DM (before 14) is a much greater risk factor for periodontal diseases than mere disease 
duration (Fig 5). 
Earlier investigators51,52 noted that the duration of DM was greater in groups with severe 
periodontal disease. Our results53 indicated that DM is associated with an increased risk of 
the development of periodontal disease in the event of an increased duration of the DM, and 
the level of oral hygiene is considered to be a contributory factor rather than the primary 
etiologic factor in the initiation of gingivitis and periodontitis in those with DM. In 
agreement with Gusberti et al.57 the findings of our study53 demonstrate that poorly 
controlled type 1 DM patients with elevated blood glucose and HbA1c levels have a greater 
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prevalence to more severe periodontal diseases. The severity of periodontal disease was 
observed to decrease as the control of the DM improved, in agreement with Tervonen and 
Knuuttila55, Rylander et al.58  
 
0
1
2
3
4
5
6
7
15-19 20-24 25-29 30-34 35-44 45-54 55+
Age/years
PI
*
 
Duration of DM: < 1year / > 1year: *P<0.001 
Duration of DM:  <1 year,  >1 year 
Fig. 4. Periodontal conditions (PI) in patients with short and long histories of DM. 
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*
 
 < 14 year / > 14 year: P<0.0001 
 < 14 year, ▧ 15-25 year,  > 25 year 
Fig. 5. Age of the patient at the onset of DM 
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Type 1 DM to increase the prevalence and severity of periodontitis independent of the 
effects of oral hygiene, and duration time of DM.42 However the severity of periodontal 
disease increased with the duration of DM only among those with an adequate level of oral 
hygiene (OHI-S = 0) The association between periodontal disease and the duration of 
diabetes mellitus is consistent with trends seen in other complications of DM whereas the 
longer duration of diabetes mellitus is in direct proportion of the prevalence and severity of 
periodontal disease. The development of systemic complications of diabetes such as 
retinopathy, nephropathy, is also is relationship with the duration of diabetes mellitus 
agreement with Rylander58, Galea et al.59, Rosenthal et al.60 and Lopez.52  
 
0
0,5
1
1,5
2
2,5
3
3,5
OHI-S PI
 
PI = The intensity of gingivitis and periodontitis 
OHI-S = oral hygiene 
OHI-S= 0 / PI: p<0.0001 
Duration time:   < 1 year   > 5 year 
Fig. 6. The intensity of gingivitis and periodontitis(PI) according to the level of oral hygiene 
(OHI-S) and the duration of DM 
On the other hand, the presence of severe periodontal infection may also increase the risk 
for microvascular and macrovascular complications. DM patients with severe periodontal 
disease demonstrate a significantly higher prevalence of proteinuria and a greater number 
of cardiovascular complications.31,54,55 Karjalainen et al.56, Genco,31 Lopez et al.52, Albrecht59 
examined the association between the severity of periodontal disease and organ 
complications (retinopathy) and found that advanced periodontal disease was associated 
with severe ophthalmic complications in type 1 DM.  
A more pronounced incidence of poor glycemic control in subjects with a shorter duration 
of DM would be consistent with the hypothesis that hyperglycemia increases linearly with 
time, but at different rates in different people. This hypothesis suggests that patients with 
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rapidly increasing hyperglycemia would have more severe periodontal disease at the onset 
of DM, resulting in damage to the periodontium. 
A positive correlation between the level of control of the disease and the intensity of 
gingivitis and periodontitis. In the well-controlled type 1 DM patients the intensity of 
gingivitis and periodontitis was lower than in those with poor glycemic control agreement 
with Gusberti et al.57, Albrecht et al.41 Good metabolic control of DM reduces the 
susceptibility to infection and is therefore also important for the prevention of periodontal 
disease in people with type 1 DM. In patients with poorly controlled DM, an improvement 
of the metabolic control may improve the periodontal condition.61-64 Conversely, periodontal 
disease can interfere with the control of DM and can increase the insulin requirements in 
previously stable patients.65-67,56,68,2,69  
Smoking is associated with an increased intensity of periodontitis. Very light or occasional 
smokers did not show statistically significant differences compared to non-smokers respect 
to the prevalence and intensity of gingivitis or periodontitis. No periodontally healthy 
subjects who has been, or who use to be heavy smokers. Tobacco contains cytotoxic 
substances such as nicotine which may also have a negative effect on the cellular turnover 
and repair of the periodontium.68,70,53 
9. Genetic predisposition and periodontal disease in type 1 DM 
Recently several study demonstrates that specific genetic markers, that have been associated 
with increased IL-1 production, are a strong indicator of susceptibility to severe periodontitis 
in healthy adults. 22,29,31 The study presented here was to explore a possible association 
between IL-1A and IL-1-B genotypes in patient with type 1 DM and controls with 
periodontitis. The frequency -in type 1 DM and controls- of the composite genotype that 
comprises allele 2 of the IL-1A plus IL-1B is shown in Fig.7. All subject were non-smokers. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
positive negative positive negative
Type 1DM control
%
 
Fig. 7. Frequency of the GenotypeR PRT positive and negative type 1 DM adult patients and 
control with periodontitis. 
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To control the effect of age on disease severity, data were analyzed separately for type 1 DM 
adolescents aged 14-19 years. In this age range, the composite genotype was present in 22,7 
% of DM adolescents and 8,57% of healthy individuals were estimated to carry the IL-1 risk 
genotype. Distribution of the PAG (Periodontitis Associated Genotype)21 positive and 
negative subjects in type 1 DM adolescents shows the Fig. 8.  
 
Type 1DM
PAG pos
Pag NEG
 
Fig. 8. Frequency of PAG positive and negative adolescents with type 1 DM  
Gingivitis was more severe in those adolescents with positive GenoTypeRPRT test (Fig.9).  
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
PAG pos PAG neg PAG pos PAG neg
Typ1 DM Type1 DM Control Control
GI
 
PAG positive/PAG negative: p<0.001 
Fig. 9. The intensity of gingivitis (GI) of PAG positiv and in negative adolescents with type 1 DM. 
■ PAG positive 
□ PAG negative 
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In type 1 DM there was significant more extracted teeth in GenotypeR PRT positive subjects 
than in negative group or non-diabetic people (p< 0.001) (Fig.10). 
 
0
2
4
6
8
10
12
14
16
pos neg pos neg
type1 DM type1DM control control
M
type1 DM pos
type1DM neg
control pos
control neg
 
P< 0.001 
Fig. 10. The mean value of extracted teeth (M) in DM patients and metabolically healthy 
individuals with positive Genotype. 
Periodontitis involves multiple clinical patterns including various severities of periodontitis, 
uncommon early onset forms that affect children and young adults with type 1 DM, and 
patients who do not respond predictably to conventional therapy refractory periodontitis.  
Guzman et al.71 have shown a possible interactions between genetic an enviromental factors 
that there is interplay between genetic an environmental factors that results in periodontal 
disease. 
The finding that a specific genotype in the IL-1 gene cluster correlates with severe periodontitis 
suggest a genetic mechanism by which some individuals, if challenged by bacterial 
accumulations, may have a more vigorous immuno-inflammatory response leading to more 
severe periodontitis in type 1 DM. The lack of reliable markers for type 1 DM patient 
susceptibility to severe periodontitis has prevented the early identification of those at most risk 
and has prevented delivery of therapy appropriate for the degree of the risk. 
10. The modification of the subgingival microflora in patients with type 1 DM 
Periodontopathogenic bacteria activate inflammatory mechanisms within the local 
periodontal tissue throught the production of toxins and other metabolites. The degree of 
this response depends on the general health and immunologic state of the patients. Besides 
that, exogenic risk factors such as heavy smoking, stress, and medication can negatively 
influence the progression of periodontal disease. Of all of the various microorganism that 
colonize the mouth in healthy subjects, there are three, Porphyromonas gingivalis, 
Actinobacillus actinomycetemcomitans, and Bacteroides forsythus have been implicated as 
etiologic agents in periodontitis. The presence of periodontal pathogen, though necessary to 
type 1 DM positive 
type 1 DM negative 
 control positive 
 ontrol negative 
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cause disease, is not sufficient. According our findings there were a significant difference 
between the severity of the gingivitis, parodontitis and the bacteria identified from the 
gingival pocket of patients with type 1 DM (Fig.11, Table 2). In case of gingivitis alone, the 
most prevalent bacterium was Bacteroides forsythus (11.11%), whereas in parodontitis it was 
Treponema denticola (75.92%). In type 1 DM the presence of Treponema denticola no additional 
risk of developing agressive periodontitis, despite the fact its presence is necessary for the 
disease to develop. The Bacteriodes forsythus, Prevotella intermedia, Porphyromonas gingivalis, 
Actinobacillus actinomicetemcomitans may be risk indicators for periodontal disease in 
population with type 1DM though they are not risk factors. 
Patients who in addition are PRT positive suffer from an overproduction of IL-1 leading to a 
significantly increased immunologic response to the presence of periodontopathogenic 
bacteria. These individuals therefore are at an even higher risk for developing severe disease 
and losing teeth. 
 
Td
Bf
Aa
Pg
Pi
 
Td: Treponema denticola 
Bf: Bacteroides forsythus 
Aa: Actinobacillus actinomycetemcomitans 
Pg: Porphyromonas gingivalis 
Fig. 11. The distribution of the subgingival microflora in adult patient with type 1 DM. 
 
Subgingival bacterial flora in type 1 DM 
Actinobacillus 
actinomycetemcomitans(Aa) 
Porphyromonas 
gingivalis (Pg) 
Prevotella 
inermedia(Pi) 
Bacteroides 
forsythus 
(Bf) 
Treponema 
denticola 
(Td) 
5% 15% 14% 31% 35% 
Table 2. Distribution of the Subgingival Microflora in Type 1 DM with Periodontal Disease 
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11. Diagnosis and therapy of periodontal disease in type 1 DM 
A considerable fraction of periodontal diseases can be stabilized for years using classical 
mechanical treatments as root planing or deep scaling. However, this treatment often is not 
sufficient for elimination of the tissue invading periodontal pathogens. Subsequently, 
progressive loss of attachment and bone tissue might occur in spite of diligent treatment. In 
these cases a specific concomitant therapy with antibiotics promises to be more efficient -of 
course only after careful microbiological testing-.  
The choice of medication and mode of application depends on the composition of the 
subgingival flora and the clinical manifestation of the periodontitis. Where tissue-invasive, 
periopathogenic bacteria such as Treponema denticola are present, mechanical methods like 
root-planing or deep-scaling are often ineffective in eliminating the pathogen. Despite 
careful treatment, the result is progressive attachment loss and bone resorption. In such 
cases, a one-of antimicrobial concomittal therapy – only undertaken after microbiological 
diagnostics, of course – is much more effective while causing less side effects. 
In the main, both local and systemic antibiotic applications are available. In the case of a 
generalized periodontal disease, an adjuvant systemic therapy is indicated. If the infection 
focus is limited to individual sites, a local treatment is a sensible alternative. 
Antibiotic therapies should in any case only be implemented after microbiological 
diagnostics (e.g.microDentR test) have been completed, in order to avoid both excessive and 
under treatment. 
In most cases a negative bacterium test result can be equated with periodontal stability. 
However, the presence of periodontal marker organisms indicates an increased risk for 
progressive destruction of the periodontium. It is obvious that a therapy with antibiotics 
should be initiated only after thorough microbiological test.  
A sustained success of the therapy depends on an optimal compliance of the patients and 
regular recall sessions. Regular control examinations of the subgingival flora are rather 
helpful in early diagnosis of potential rezidives.  
Genetics factors should also be determined because they play a key role in providing 
information to make better treatment decisions. A genotype result is always important to 
consider when making treatment decisions, even if the patient is genotype-negative. A 
negative result does not mean that a patient will be periodontal-disease-free. Genotype 
negative individuals must still be cautious about other risk factors, such as stress, smoking, 
bad oral hygiene-, and diabetes control. 
The genetic predictive test for periodontitis complements the dentist’s full scope of services 
by providing additional wanted and useful information. Indications for the genetic 
predictive test may be of value to the following patients groups: 
 DM patients exhibiting refractory, therapy-resistent periodontitis. A positive test result 
might explain previous treatment failures and is an indicator for planing an alternative 
therapy. 
 DM patients exhibiting progressive periodontitis. A positive test result might indicate 
the necessity for a more agressive therapy and shortes recall intervals. 
 Type 1 DM adolescens -under 14 years- exhibiting early clinical sign of periodontitis. 
Before starting treatment, the test helps to plan an individual therapy maching the 
patient’s t.i. a therapy stopping progress of the disease without risking over-treatment. 
 Haewy smokers patients with type 1 DM. 
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Treatment decisions will be affected if a patient has risk factors, for example, haevy smokers. 
Haevy smokers are counseled that the treatment outcome from regenerative therapy will 
not be as good as outcomes for those who do not smoke. 
In all cases where patient motivation and compliance are major obstacles to efficient 
prophylactic measures the situation can be dramatically improved when high risk patients 
are informed about their condition. 
Knowledge of the IL-1 genotype, the bacterial load, and possible additional risk factors 
allow for the prediction of the patient’s future periodontal status including the risk of 
further tooth loss. For the first time, these data enable the dentist to plan an individual 
therapy matching the patient’s needs. Knowledge of the IL-1 genotype also allows a more 
efficient therapy from an economic point of view because over- and under-treatment can be 
minimized.  
12. Conclusion 
Periodontitis is a complex multifactorial disease. Similarly, Type 1 DM is a complex 
metabolic syndrome. Periodontal disease can be especially problematic for individuals with 
type 1 DM, in whom the disease may have an early onset or may progress more rapidly. 
Many characteristics and local factors such as dental calculus, the smoking habits and 
general factors (the duration of DM, the age, the degree of metabolic control, and the 
complications of DM) have been identified as factors that put people et an enhanced risk. 
The initial dental therapy for patients with type 1 DM, as for all patients, must be directed 
toward the control of acute oral infections at the onset of DM. It is important to advise the 
phisician of the periodontal status, since the presence of infections including advanced 
periodontal disease may increase the insulin resistance and cotribute to a worsening of the 
DM state. Regular dental care may help maintain good oral health and it is especially 
important at the onset of the disease. Patients should also be checked regularly for bleeding 
gums or inflammation. Educating the patient in proper home oral care is a standard routine 
of periodontal treatment and prevention. Plaque control and scaling procedures frequently 
resolve gingivitis. However, where more tissue destruction has occurred, it may still be 
difficult or impossible for the patient to remove plaque deposits from the periodontal 
pockets.  
Periodontitis is a disease leading to destruction of connective tissue and bone that support 
the teeth. Due to the multifunctional etiology of the disease its clinical appearence and 
progression greatly vary resulting in difficulties in planing an effective therapy. Smoking 
should be avoided because it is associated with an increased intensity of periodontitis.  
Patients who are genotype positive do not lose all of their teeth to periodontitis because, for 
the most part, it is a treatable and preventable disease. If patients are identified as having 
the genetic susceptibility factor and begin a treatment or prevention plan, there are high 
expectations for favorable outcomes and there is no known risk from being tested. 
Determining the patient’s genetic susceptibility in the future helps to plan a comprehensiv 
therapy and regular dental control to improve patients care prevent to developing severe, 
generalized periodontitis and toothlos. This IL-1 genotype does not cause periodontal 
disease directly, this marker is not a causative factor, instead it is a severity risk factor for 
susceptibility or predisposition to periodontitis. Optimal prophylaxis and efficient therapy 
of the polymorphisms defining the periodontitis risk genotype (PRT-positive) patients a 
careful microbiological testing of the subgingival bacterial flora for allows for the timely 
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application of appropriate therapeutic measures. In case of positive test results proving the 
presence of specific periodontopathogenic bacterial species antibiotics should be applied. 
Choice of medication and mode of application depend on the composition of the 
subgingival flora and the clinical manifestation of the periodontal disease. 
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